87
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Translation, Cross-Cultural Adaptation, and Measurement Properties of the Portuguese Version of the Global Trigger Tool for Adverse Events

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1175-1183 | Published online: 03 Dec 2020
 

Abstract

Purpose

To adapt and validate the Global Trigger Tool (IHI-GTT), which identifies and analyzes adverse events (AE) in hospitalized patients and their measurement properties in the Portuguese context.

Methods

A retrospective cross-sectional study was based on a random sample of 90 medical records. The stages of translation and cross-cultural adaptation of the IHI-GTT were based on the Cross-Cultural Adaptation Protocol that originated from the Portuguese version, GTT-PT, for the hospital context in medical-surgical departments. Internal consistency, reliability, reproducibility, diagnostic tests, and discriminatory predictive value were investigated.

Results

The final phase of the GTT-PT showed insignificant inconsistencies. The pre-test phase confirmed translation accuracy, easy administration, effectiveness in identifying AEs, and relevance of integrating it into hospital risk management. It had a sensitivity of 97.8% and specificity of 74.8%, with a cutoff point of 0.5, an accuracy of 83%, and a positive predictive value of 69.8% and a negative predictive value of 0.98%.

Conclusion

The GTT-PT is a reliable, accurate, and valid tool to identify AE, with robust measurement properties.

Acknowledgments

The authors thank the authors of the tool for authorizing its translation and validation, the FG members who participated in the translation and back-translation stages, the nurses from Lagos Medical Service who collaborated in data collection, and the CHUA hospital administration for authorizing the present study.

Disclosure

This study was part of the PhD program in Health Sciences at the University of Seville. The authors declare no conflicts of interest.

Additional information

Funding

There is no funding to report.